Research and Development

The Research and Development team at Verve Therapeutics is dedicated to pioneering innovative genomic editing therapies aimed at providing lasting protection against coronary artery disease. Comprised of skilled scientists and associates specializing in areas such as bioanalysis, pharmacology, and computational biology, the team collaborates to discover and optimize novel therapeutic approaches while rigorously evaluating their safety and efficacy across preclinical and clinical stages of development.